1. Home
  2. VALN vs FISI Comparison

VALN vs FISI Comparison

Compare VALN & FISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • FISI
  • Stock Information
  • Founded
  • VALN 2012
  • FISI 1817
  • Country
  • VALN France
  • FISI United States
  • Employees
  • VALN N/A
  • FISI N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • FISI Major Banks
  • Sector
  • VALN Health Care
  • FISI Finance
  • Exchange
  • VALN Nasdaq
  • FISI Nasdaq
  • Market Cap
  • VALN 488.9M
  • FISI 416.4M
  • IPO Year
  • VALN 2021
  • FISI 1999
  • Fundamental
  • Price
  • VALN $4.66
  • FISI $26.83
  • Analyst Decision
  • VALN Strong Buy
  • FISI Hold
  • Analyst Count
  • VALN 2
  • FISI 2
  • Target Price
  • VALN $18.50
  • FISI $22.00
  • AVG Volume (30 Days)
  • VALN 22.7K
  • FISI 43.4K
  • Earning Date
  • VALN 11-07-2024
  • FISI 10-24-2024
  • Dividend Yield
  • VALN N/A
  • FISI 4.47%
  • EPS Growth
  • VALN N/A
  • FISI N/A
  • EPS
  • VALN N/A
  • FISI 3.17
  • Revenue
  • VALN $176,817,979.00
  • FISI $216,605,000.00
  • Revenue This Year
  • VALN $24.30
  • FISI N/A
  • Revenue Next Year
  • VALN $16.05
  • FISI $6.94
  • P/E Ratio
  • VALN N/A
  • FISI $8.46
  • Revenue Growth
  • VALN N/A
  • FISI 9.25
  • 52 Week Low
  • VALN $4.60
  • FISI $16.29
  • 52 Week High
  • VALN $12.85
  • FISI $28.12
  • Technical
  • Relative Strength Index (RSI)
  • VALN 26.32
  • FISI 56.62
  • Support Level
  • VALN $4.63
  • FISI $26.53
  • Resistance Level
  • VALN $5.28
  • FISI $28.12
  • Average True Range (ATR)
  • VALN 0.18
  • FISI 0.70
  • MACD
  • VALN -0.09
  • FISI 0.20
  • Stochastic Oscillator
  • VALN 4.05
  • FISI 70.95

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

About FISI Financial Institutions Inc.

Financial Institutions Inc operates as a financial holding company, engages in the provision of a wide range of consumer and commercial banking services to individuals, municipalities, and businesses in Western and Central New York. It operates through one segment: The Banking segment which includes all of the company's retail and commercial banking operations.

Share on Social Networks: